A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Conditions
Prostatic Neoplasms
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
University Of Minnesota, Minneapolis, Minnesota, United States
START New Jersey, East Brunswick, New Jersey, United States
Herbert Irving Comprehensive Cancer Center Columbia University Medical Center, New York, New York, United States
Oregon Health And Science University, Portland, Oregon, United States
Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia, Pennsylvania, United States
Tennessee Oncology, Nashville, Tennessee, United States
MD Anderson Cancer Center, Houston, Texas, United States
South Texas Accelerated Research Therapeutics, LLC (START), San Antonio, Texas, United States
Swedish Medical Center, Seattle, Washington, United States
Peter MacCallum Cancer Centre, Melbourne, Australia
Institut Bergonie, Bordeaux, France
Centre Leon Berard, Lyon, France
Institut Gustave Roussy, Villejuif, France
The Cancer Institute Hospital of JFCR, Tokyo, Japan
Study leads
Janssen Research & Development, LLC Clinical Trial
Study Director
Janssen Research & Development, LLC